Medical Condition News

RSS

Evidence-based review of TBI in sport

Experts from Johns Hopkins Medicine hosted a press conference following a continuing medical education program on the epidemiology of head injury in professional football. The program was an evidence-based review of traumatic brain injury in the sport.

14 Jun 2010

Study finds survival disparities among patients with colorectal cancer

Disparities in cancer stage and treatment are the main reasons why Medicaid-insured and uninsured rectal cancer patients are twice as likely to die within five years as privately insured patients. That is the conclusion of a new study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. Because poorer survival among rectal cancer patients without private insurance is largely attributable to later cancer stage at diagnosis and inadequate treatment, disparities may be lessened through health care reform.

14 Jun 2010

UJI participates in project OPTIMI for early detection of depression

Treatments for mental illnesses are based on medicines and on therapies. Nevertheless it is not being done much to develop effective systems to prevent the appearance of such illnesses. In January starts the European initiative OPTIMI to contribute to the early detection of depression. The research group Labpsitec of the Department of Basic and Clinical Psychology and Psychobiology at the Universitat Jaume I of Castellón, takes part in the project with the design of evaluation strategies for people in situation of risk.

14 Jun 2010

Astrocytes involved in regulation of signalling between neurons: Study

Astrocytes are the most common type of cell in the brain and play an important role in the function of neurons - nerve cells. New research from the University of Gothenburg, Sweden, shows that they are also directly involved in the regulation of signalling between neurons.

14 Jun 2010

ARBs increase risk of cancer: Study

University Hospitals Case Medical Center cardiologists have uncovered new research showing an increased risk of cancer with a group of blood pressure medications known as angiotensin-receptor blockers (ARBs).

14 Jun 2010

National MS Society commits over $2.4M to support 7 CCSVI research projects

Over $2.4 million has been committed by the National MS Society (USA) and the MS Society of Canada to support 7 new research projects focusing on the role of CCSVI in MS.

14 Jun 2010

Researchers show personal factors play major role in deciding duration of sick leave

Patients, sick-listed for back and neck problems return to work at different rates despite having similar problems, and personal factors play a major role, reveals a thesis from the University of Gothenburg, Sweden.

14 Jun 2010

Study confirms impact of febrile neutropenia on chemotherapy delivery in NHL

Data presented at the 15th European Hematology Association (EHA) congress in Barcelona, highlights the impact of febrile neutropenia (FN) on chemotherapy delivery in non-Hodgkin lymphoma (NHL) patients. The IMPACT NHL study showed that unplanned hospitalisations, delays in chemotherapy and reductions of chemotherapy dose leading to suboptimal relative dose intensity (RDI) of chemotherapy were more frequent in patients who experienced FN than those who did not.

14 Jun 2010

Nexavar does not meet primary endpoint in Phase 3 NExUS trial for advanced NSCLC

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced that the final analysis of the Phase 3 NExUS (NSCLC research Experience Utilizing Sorafenib) trial evaluating Nexavar® (sorafenib) tablets in patients with advanced non-squamous non-small cell lung cancer (NSCLC) showed that the study did not meet its primary endpoint of improving overall survival in the first-line setting.

14 Jun 2010

CTI announces AIFA approval for manufacture of pixantrone at NerPharMa facility

Cell Therapeutics, Inc. today announced that the Italian Medicines Agency ("AIFA"), the national authority responsible for drug regulation in Italy, has approved the facility at NerPharMa DS (a pharmaceutical manufacturing company belonging to Nerviano Medical Sciences Srl, in Nerviano, Italy) for the production of CTI's drug candidate pixantrone.

14 Jun 2010

Phase III study of REVLIMID for treating patients with multiple myeloma shows improvement in PFS

Celgene International Sàrl announced that data from the planned second interim analysis (median follow-up of 21 months) of a phase III, randomized, double-blind study of continuous REVLIMID (lenalidomide) for the treatment of elderly patients with newly diagnosed multiple myeloma show improvement in progression-free survival, the primary endpoint of the study.

14 Jun 2010

New SACS Instrument launched to assess and classify peristomal skin lesions

A new evidence-based instrument to assess and classify peristomal skin lesions was launched at the 2010 Joint Conference of the Wound, Ostomy and Continence Nurses Society and World Council of Enterostomal Therapists. The instrument, known as the SACS Instrument, represents the first content-validated instrument to objectively assess and classify peristomal lesions by type and location in relation to an individual's stoma.

14 Jun 2010

Telmisartan reduces hypertension, cardiovascular risk in ACE-intolerant patients: Boehringer Ingelheim

Telmisartan, an angiotensin receptor blocker, is one of the best researched drugs worldwide. It has been studied in clinical trials in more than 50,000 patients. Its positive safety profile has been confirmed also in a market exposure of 34.5 million patient years. Convincing safety data for patients with a high cardiovascular risk were collected in the three long-term outcome trials ONTARGET, PRoFESS and TRANSCEND which followed some of the patients for up to five years.

14 Jun 2010

Researchers find new way to prevent blindness caused by retinitis pigmentosa

Researchers at the University of Oklahoma Health Sciences Center have found a way to use a radical new type of gene therapy to prevent blindness caused by retinitis pigmentosa, giving hope to the estimated 100,000 Americans who suffer from this debilitating disease.

14 Jun 2010

Blood flow interruption during renal surgery can increase risk of chronic kidney disease

Interrupting the blood flow for more than 20 to 25 minutes during kidney cancer (http://www.mayoclinic.org/kidney-cancer/research.html) surgery leads to a greater risk for patients developing chronic kidney disease, a Mayo Clinic and Cleveland Clinic collaborative research team has found. The study was published today in the journal, European Urology.

14 Jun 2010

Olfactory function tests could help in treating patient in early stages of PD

A fast, simple and non invasive test of the ability to smell may be an important tool to screen people who are likely to develop Parkinson's disease, in which motor symptoms only become evident at a later stage of the disease, a German scientist will tell the annual conference of the European Society of Human Genetics today (Saturday).

14 Jun 2010

TWI launches new educational module to understand role of biofilms in chronic wound infections

The Wound Institute today announced the launch of a new educational module "Exploring Biofilms," an accredited, online course designed to help practicing wound care specialists better understand the role that biofilms play in chronic wound infections.

14 Jun 2010

Asymptomatic perioperative arrhythmias can lead to sudden cardiac death after surgery: Researchers

Vascular surgery may be accompanied by cardiovascular complications, like ventricular tachyarrhythmia. Though, these arrhythmias initially might be asymptomatic, they can lead to increased risk for late sudden cardiac death after surgery. Researchers from the Netherlands believe that cardiac high-risk patients with new-onset perioperative VT might benefit from preemptive cardioverter defibrillator implantation in addition to optimal focused medical therapy.

14 Jun 2010

First database of combined clinical trials on brain disease made available to qualified researchers

A new database of more than 4,000 Alzheimer's disease patients who have participated in 11 industry-sponsored clinical trials was released today by the Coalition Against Major Diseases. This is the first database of combined clinical trials to be openly shared by pharmaceutical companies and made available to qualified researchers around the world.

14 Jun 2010

Cancer survivors forego medical care because of financial concerns

A new analysis has found that two million cancer survivors did not get needed medical services in the previous year because of concerns about cost. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study raises the concern that the long-term health and well-being of cancer survivors could suffer because patients have financial worries about their care.

14 Jun 2010

Medical Condition News

Evidence-based review of TBI in sport

Study finds survival disparities among patients with colorectal cancer

UJI participates in project OPTIMI for early detection of depression

Astrocytes involved in regulation of signalling between neurons: Study

ARBs increase risk of cancer: Study

National MS Society commits over $2.4M to support 7 CCSVI research projects

Researchers show personal factors play major role in deciding duration of sick leave

Study confirms impact of febrile neutropenia on chemotherapy delivery in NHL

Nexavar does not meet primary endpoint in Phase 3 NExUS trial for advanced NSCLC

CTI announces AIFA approval for manufacture of pixantrone at NerPharMa facility

Phase III study of REVLIMID for treating patients with multiple myeloma shows improvement in PFS

New SACS Instrument launched to assess and classify peristomal skin lesions

Telmisartan reduces hypertension, cardiovascular risk in ACE-intolerant patients: Boehringer Ingelheim

Researchers find new way to prevent blindness caused by retinitis pigmentosa

Blood flow interruption during renal surgery can increase risk of chronic kidney disease

Olfactory function tests could help in treating patient in early stages of PD

TWI launches new educational module to understand role of biofilms in chronic wound infections

Asymptomatic perioperative arrhythmias can lead to sudden cardiac death after surgery: Researchers

First database of combined clinical trials on brain disease made available to qualified researchers

Cancer survivors forego medical care because of financial concerns

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Latest News